About Us
Michael Ackermann, Ph.D.
Chairman
Michael is a co-founder of Tarsus and currently serves as the Chairman of the Board. Michael also serves as Chairman of Oyster Point Pharma, Inc. (NASDAQ: OYST) and Chairman of Presidio Medical, Inc. He was previously Vice President, Neurostimulation for Allergan, plc after serving as CEO of Oculeve, Inc., which was acquired by Allergan. He received a B.E. degree in biomedical engineering from Vanderbilt University; M.S. and Ph.D. degrees in biomedical engineering from Case Western Reserve University; is a graduate of the Stanford University Biodesign Fellowship; and Vision Research Fellowship at Stanford University. He has numerous patents and peer-reviewed publications.